Glucagon-like peptide-1 analog
Jump to navigation Jump to search
Editor-In-Chief: C. Michael Gibson, M.S., M.D. 
Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes.  One of their advantages is that they have a lower risk of causing hypoglycemia.
- exenatide (2005)
- ↑ http://www.medscape.com/viewarticle/578304 "Glucagon-like Peptide-1 Analogs Other Than Exenatide"